Multiple Sclerosis Treatment Shared Decision Making Healthywomen Shared decision making (sdm) between the patient and their healthcare provider (hcp) in developing treatment plans is increasingly recognized as central to improving treatment adherence and, ultimately, patient outcomes. Current views and opinions on shared decision making for the treatment of ms are discussed in this consensus based on a modified delphi method that included a group of neurologists from argentina.
Multiple Sclerosis Treatment Shared Decision Making People with multiple sclerosis (pwms) want more involvement in decisions about dmts, but new approaches are needed to support shared decision making (sdm) because of the number of treatment options and the range of outcomes affected by treatment. Given the preference sensitive nature of many key decisions to be made, and the increasing numbers of disease modifying therapies, shared decision making (sdm) with patients seems to be key in offering optimum care and outcomes for people suffering from ms. Several treatments are available that modify the course of the disease and reduce the frequency of relapses. although effective, all treatment options are accompanied by adverse events, and this study aimed to assess the extent to which patients were involved in the choice of treatment. Shared decision making (sdm) between the patient and their healthcare provider (hcp) in developing treatment plans is increasingly recognized as central to improving treatment adherence.
Navigating Treatment Decision Making In Multiple Sclerosis Several treatments are available that modify the course of the disease and reduce the frequency of relapses. although effective, all treatment options are accompanied by adverse events, and this study aimed to assess the extent to which patients were involved in the choice of treatment. Shared decision making (sdm) between the patient and their healthcare provider (hcp) in developing treatment plans is increasingly recognized as central to improving treatment adherence. Literature about patient education and outcomes of shared decision aids in multiple sclerosis has been growing over the last decade. in this topical review, we present an overview of the current literature on shared decision making in multiple sclerosis. This study aimed to investigate how shared decision making (sdm) and the use of different types of outcome information are applied in routine care management for people with multiple sclerosis (ms) in an academic outpatient clinic. Several treatments are available that modify the course of the disease and reduce the frequency of relapses. although effective, all treatment options are accompanied by adverse events, and this study aimed to assess the extent to which patients were involved in the choice of treatment. Shared decision making is highlighted as a collaborative process between doctors and patients, where individual preferences and risks are carefully considered. patients' voices are integral to treatment decisions, especially when they express reluctance towards certain therapies.
Comments are closed.